As official media partners, VJHemOnc is thrilled to present updates from the 46th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT).
This year’s meeting shed light on the latest research and education in hematological transplantation and cellular therapies.
View all videosEBMT 2020
FDA approves Oncopeptides' PEPAXTO® ( melphalan flufenamide) for patients with relapsed or refractory multiple myeloma https://news.cision.com/oncopeptides-ab/r/fda-approves-oncopeptides--pepaxto----melphalan-flufenamide--for-patients-with-relapsed-or-refractor,c3296082 via @cision
@Mohty_EBMT @COMyCongress @mvmateos @NBahlis @mbeksac56 @rabonour1 @DrGarethMorgan1 @OcioEnrique @BrunoPaiva_UNAV @profBigG @VincentRK @NoopurRajeMD @szusmani @End_myeloma @myelomatom @DMadduri @AjaiChari @nagler_EBMT @TheIACH If you are interested in myeloma this is a DO NOT MISS MEETING. Free, fantastic faculty and great up to date coverage of all the new data with plenty of useful discussion. @Mohty_EBMT @COMyCongress ..the real question is why would you not join in ?????
#RareDiseaseDay |Shout outs to all who have worked w/me to champion the #RareDisease field : 🙏 @LLSusa @PatientPower @power4patients @DavidFajgenbaum @lane_andy @marklewismd @mtmdphd @mpnadvocacy @mpdrc @BldCancerDoc @DrMiguelPerales #MPNSM #BPDCN #Castleman #leusm #Ayacsm 🙌
4EBMT 2020
As official media partners, VJHemOnc is thrilled to present updates from the 46th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT).
This year’s meeting shed light on the latest research and education in hematological transplantation and cellular therapies.
View all videosFDA approves Oncopeptides' PEPAXTO® ( melphalan flufenamide) for patients with relapsed or refractory multiple myeloma https://news.cision.com/oncopeptides-ab/r/fda-approves-oncopeptides--pepaxto----melphalan-flufenamide--for-patients-with-relapsed-or-refractor,c3296082 via @cision
@Mohty_EBMT @COMyCongress @mvmateos @NBahlis @mbeksac56 @rabonour1 @DrGarethMorgan1 @OcioEnrique @BrunoPaiva_UNAV @profBigG @VincentRK @NoopurRajeMD @szusmani @End_myeloma @myelomatom @DMadduri @AjaiChari @nagler_EBMT @TheIACH If you are interested in myeloma this is a DO NOT MISS MEETING. Free, fantastic faculty and great up to date coverage of all the new data with plenty of useful discussion. @Mohty_EBMT @COMyCongress ..the real question is why would you not join in ?????
#RareDiseaseDay |Shout outs to all who have worked w/me to champion the #RareDisease field : 🙏 @LLSusa @PatientPower @power4patients @DavidFajgenbaum @lane_andy @marklewismd @mtmdphd @mpnadvocacy @mpdrc @BldCancerDoc @DrMiguelPerales #MPNSM #BPDCN #Castleman #leusm #Ayacsm 🙌
4
